Cardiopulmonary exercise testing in systolic heart failure in 2014: The evolving prognostic role A position paper from the committee on exercise physiology and training of the heart failure association of the ESC

European Journal of Heart Failure

Volumn 16, Issue 9, 2014, Pages 929-941

  Corrà, Ugo ^a   Piepoli, Massimo F ^b   Adamopoulos, Stamatis ^c   Agostoni, Piergiuseppe ^d   Coats, Andrew J S ^e   Conraads, Viviane ^f   Lambrinou, Ekaterini ^g   Pieske, Burkert ^h   Piotrowicz, Ewa ⁱ   Schmid, Jean Paul ^j   Seferovíc, Petar M ^k   Anker, Stefan D ^l   Filippatos, Gerasimos ^m   Ponikowski, Piotr P ⁿ  

^a IRCCS   (Italy)

^b GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

^d CENTRO CARDIOLOGICO MONZINO   (Italy)

^e MONASH UNIVERSITY   (Australia)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁱ INSTITUTE OF CARDIOLOGY   (Poland)

^j UNIVERSITY OF BERN   (Switzerland)

^k UNIVERSITY OF BELGRADE   (Serbia)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

ⁿ WROCLAW MEDICAL UNIVERSITY   (Poland)

more..

Author keywords

Dystolic heart failure; Exercise testing; Prognosis

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ALGORITHM; ANAEROBIC THRESHOLD; CARDIAC PATIENT; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; DIAGNOSTIC TEST ACCURACY STUDY; DONOR; ELECTROCARDIOGRAM; END TIDAL CARBON DIOXIDE TENSION; EXERCISE PHYSIOLOGY; HEALTH CARE ORGANIZATION; HEART ARRHYTHMIA; HEART RATE; HEART TRANSPLANTATION; HUMAN; LEAN BODY WEIGHT; OXYGEN CONSUMPTION; PRESSURE; PROGNOSIS; REVIEW; STRATIFICATION; SYSTOLIC HEART FAILURE; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE, SYSTOLIC; MEDICAL SOCIETY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; STANDARDS;

EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE, SYSTOLIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SOCIETIES, MEDICAL;

EID: 84908258827     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.156     Document Type: Review

References (125)

1. American Thoracic Society/American College of Chest Physicians. Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003;167:211-277.
2. Piepoli MF, Corra U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part III: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. Eur J Cardiovasc Prev Rehabil 2006;13:485-494.
3. Mezzani A, Agostoni PG, Cohen-Solal A, Corrà U, Jegier A, Kouidi E, Mazic S, Meurin P, Piepoli P, Simon A, Van Laethem C, Vanhees L. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: A report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2009;16:249-267.
4. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Gerald F, Fletcher GF, Daniel E, Forman DE, Kitzman DW, Lavie CJ, Myers J. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012;33:2917-2927.
5. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: Analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol 2007;50:1282-1290.
6. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
7. Piepoli MF, Corra U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part II: How to perform cardiopulmonary exercise testing in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006;13:300-311.
8. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, Forman D, Franklin B, Guazzi M, Gulati M, Keteyian SJ, Lavie CJ, Macko R, Mancini D, Milani RV. Clinician's guide to cardiopulmonary exercise testing in adults. A Scientific Statement from the American Heart Association. Circulation 2010;122:191-225.
9. Ileana L. Piña IL, Apstein CS, J. Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ. Exercise heart failure. A Statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Circulation 2003;107:1210-1225.
10. Piepoli MF, Guazzi M, Boriani G, Cicoira M, Corra' U, Dalla Libera L, Emding M, Mele D, Passino C, Vescovo G, Vigorito C, Villani CQ, Agostoni PG; on behalf of the Working Group 'Exercise Physiology. Sport Cardiology and Cardiac Rehabilitation' of the Italian Society of Cardiology (Italian Federation of Cardiology). Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil 2010;17:637-642.
11. Piepoli MF, Guazzi M, Boriani G, Cicoira M, Corra' U, Dalla Libera L, Emding M, Mele D, Passino C, Vescovo G, Vigorito C, Villani CQ, Agostoni PG; on behalf of the Working Group 'Exercise Physiology, Sport Cardiology and Cardiac Rehabilitation' of the Italian Society of Cardiology (Italian Federation of Cardiology). Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. Eur J Cardiovasc Prev Rehabil 2010;17:643-648.
12. Sullivan MJ, Cobb FR. Central hemodynamic response to exercise in patients with chronic heart failure. Chest 1992;101(5 suppl):340S-346S.
13. Shen WF, Roubin GS, Hirasawa K, Choong CY, Hutton BF, Harris PJ, Fletcher PJ, Kelly DT. Left ventricular volume and ejection fraction response to exercise in chronic congestive heart failure: difference between dilated cardiomyopathy and previous myocardial infarction. Am J Cardiol 1985;55:1027-1031.
14. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-1087.
15. Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996;28:1092-1102.
16. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993;22:72A-84A.
17. Weber KT, Janicki JS, McElroy PA. Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation 1987;76:VI40-VI45.
18. Wasserman K, Zhang YY, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997;96:2221-2227.
19. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJ. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 1996;93:940-952.
20. Tumminello G, Guazzi M, Lancellotti P, Pierard LA. Exercise ventilation inefficiency in heart failure: pathophysiological and clinical significance. Eur Heart J 2007;28:673-678.
21. Hollenberg M, Tager IB. Oxygen uptake efficiency slope: An index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. J Am Coll Cardiol 2000;36:194-201.
22. Mancini DM, Eisen H, KussmaulW, Mull R, Edmund LH, Wilson JR. Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-786.
23. Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Md, Shaw LJ, Kargl D, Chaitman BR. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996;27:345-352.
24. Aaronson KD, Mancini DM. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? J Heart Lung Transplant 1995;14:981-989.
25. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Forman D, West E, Guazzi M. Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure. Circ Heart Fail 2009;2:113-120.
26. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985;131:700-708.
27. Wasserman K, Hansen JE, Sue DY, Stringer W, Whipp BJ. Normal values. In Weinberg R, ed. Principles of Exercise Testing and Interpretation, 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005. pp160-182.
28. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984;129:S49-S55.
29. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol 1993;22:175-182.
30. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH, Al-Hani AJ, Black HR. Exercise capacity and the risk of death in women: The St. James Women Take Heart Project. Circulation 2003;108:1554-1559.
31. Barlow CE, LaMonte MJ, Fitzgerald SJ, Kampert JB, Perrin JL, Blair SN. Cardiorespiratory fitness is an independent predictor of hypertension incidence among initially normotensive healthy women. Am J Epidemiol 2006;163:142-150.
32. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS Jr, Blair SN. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999;282:1547-1553.
33. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000;36:2126-2131.
34. Cohen-Solal A, Barnier P, Pessione F, Seknadji LD, Laperche T, Gougorn R. Comparison of the long-term prognostic value of peak exercise oxygen pulse and peak oxygen uptake in patients with chronic heart failure. Heart 1997;78:572-576.
35. Lavie CJ, Milani RV, Mehra MR. Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol 2004;93:588-593.
36. Oliveira RB, Myers J, Ph Dg, Araújo CGS, Arena R, Mandic S, Bensimhon D, Abella J, Chase P, Guazzi M, MD, Brubaker P, Brian Moore B, Kitzman D, Peberdy MA. Does peak oxygen pulse complement peak oxygen uptake in risk stratifying patients with heart failure? Am J Cardiol 2009;104:554-558.
37. Mezzani A, Corrà U, Giordano A, Giannuzzi P. Contribution of peak respiratory exchange ratio to peak VO2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity. Am Heart J 2003;145:1102-1107.
38. Pardaens K, Van Cleemput J, Vanhaecke J, Fagard RH. Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates. Circulation 2000;101:1152.
39. Ingle L, Witte KK, Cleland JGJF, Clark AL. The prognostic value of cardiopulmonary exercise testing with a peak respiratory exchange ratio of <1.0 in patients with chronic heart failure. Int J Cardiol 2008;127:88-92.
40. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Influence of subject effort on the prognostic value of peak VO2 and the VE/VCO2 slope in patients with heart failure. J Cardiopulm Rehabil 2004;24:317-320.
41. Wood PR, Baily KR, Wood CM, Johnson BD. Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure. Eur J Heart Fail 2011;13:303-310.
42. Chase PJ, Kenjale A, Cahalin LP, PHD, Arena R, Davis PG, Myers J, Guazzi M, Forman DE, Ashley E, Peberdy MA, West E, Kelly CT, Bensimhon DR. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail 2013;1:427-432.
43. Osada N, Chaitman BR, Miller LW, Yip D, Cishek MB, Wolford TL, Donohue TJ. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol 1998;31:577-582.
44. Williams SG, Jackson M, Ng LL, Barker D, Patwala A, Tan LB. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology 2005;104:221-226.
45. Corrà U, Mezzani A, Giordano A, Bosimini E, Giannuzzi P. Exercise hemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol. Eur Heart J 2009;27:684-690.
46. Cohen-Solal A, Beauvais F, Tan LB. Peak exercise responses in heart failure: back to basics. Eur Heart J 2009;30:2962-2964.
47. Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet 1986;ii:1360-1363.
48. Lang CC, Agostoni P, Mancini DM. Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. J Cardiac Fail 2007;13:672-669.
49. Williams SG, Jackson M, Cooke GA, Barker D, Patwala A, Wright DJ, Albuoaini K, Tan LB. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure. Am Heart J 2005;150:983e1-986e1.
50. Scharf C, Merz T, Kiowski W, Oechslin E, Schalcher C, Brunner-La Rocca HP. Noninvasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure. Chest 2002;122:1333-1339.
51. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P, Tan LB. Peak cardiac power output. A direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22:1496-1503.
52. Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J 2002;23:806-814.
53. Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K. Oxygen uptake efficiency slope: A new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996;28:1567-1572.
54. Van Laethem C, Bartunek J, Goethals M, Nellens P, Andries E, Vanderheyden M. Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patients. Am Heart J 2005;149:175-180.
55. Davies LC, Wensel R, Georgiadou P, Cicoira M, Coats AJ, Piepoli MF, Francis DP. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J 2006;27:684-690.
56. Van Laethem C, Van De Veire N, De Backer G, Bihija S, Seghers T, Cambier D, Vanderheyden M, De Sutter J. Response of the oxygen uptake efficiency slope to exercise training in patients with chronic heart failure. Eur J Heart Fail 2007;9:625-629.
57. Arena R, Myers J, Hsu L, Peberdy MA, Pinkstaff S, Bensimhon D, Chase P, Vincenzi M, Guazzi M. The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Cardiac Fail 2007;13:462-469.
58. Matsumoto A, Itoh H, Eto Y, Kobayashi T, Kato M, Omata M, Watanabe H, Kato K, Momomura S. End-tidal CO2 pressure decreases during exercise in cardiac patients: Association with severity of heart failure and cardiac output reserve. J Am Coll Cardiol 2000;36:242-249.
59. Tanabe Y, Hosaka Y, Ito M, Ito E, Suzuki K. Significance of end-tidal P(CO(2)) response to exercise and its relation to functional capacity in patients with chronic heart failure. Chest 2001;119:811-817.
60. Arena R, Guazzi M, Myers J. Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure. Int J Cardiol 2007;117:103-108.
61. Arena R, Humphery R. Comparison of ventilatory expired gas parameters used to predict hospitalization in patients with heart failure. Am Heart J 2002;143:427-432.
62. Arena R, Peberdy MA, Myers J, Guazzi M, Tevald M. Prognostic value of resting end-tidal carbon dioxide in patients with heart failure. Int J Cardiol 2006;109:351-358.
63. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Guazzi M. The partial pressure of resting end-tidal carbon-dioxide predicts major cardiac events in patients with systolic heart failure. Am Heart J 2008;156:982-988.
64. MacGowan GA, Janosko K, Cecchetti A, Murali S. Exercise-related ventilatory abnormalities and survival in congestive heart failure. Am J Cardiol 1997;79:1264-1266.
65. Whipp BJ, Ward SA, Wasserman K. Ventilatory responses to exercise and their control in man. Am Rev Respir Dis 1984;129(Suppl):S17-S20.
66. Hsia CCW, Johnston RL Jr. Exercise physiology and lung diseases. In: Bone R, ed. Comprehensive Textbook of Pulmonary and Critical Care Medicine. St Louis: Mosby-Yearbook; 1993. p1-20.
67. Wensel R, Georgiadou P, Francis DP, Bayne S, Scott AC, Genth-Zotz S, Anker SD, Coats AJ, Piepoli MF. Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:318-323.
68. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, Poole-Wilson PA, Coats AJS. Clinical correlates and prognostic significance of the ventilatory response to exercise in CHF. J Am Coll Cardiol 1997;29:1585-1590.
69. Robbins M, Francis G, Pashkow FJ, Snader CE, Hoercher K, Young JB, Lauer MS. Ventilatory and heart rate response to exercise. Better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999;100:2411-2417.
70. Gitt A, Wasserman K, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002;106:3079-3084.
71. Francis DP, Shamin W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, Coats AJ. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2 slope and peak VO2. Eur Heart J 2000;21:154-161.
72. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, Sperfeld A, Glaser S. Impairment of ventilatory efficiency in heart failure. Prognostic impact. Circulation 2000;10:2803-2309.
73. Corrà U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ventilatory response to exercise improves risk stratification in chronic heart failure patients with intermediate functional capacity. Am Heart J 2002;143:418-426.
74. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, Guazzi M. Development of ventilatory classification system in patients with heart failure. Circulation 2007;115:2410-17.
75. Tabet JY, Beauvais F, Thabut G, Tartiere JM, Logeart D, Cohen-Solal A. A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure patients. Eur J Cardiovasc Prev Rehabil 2003;10:267-272.
76. Guazzi M, De Vita S, Cardano P, PhD, Barlera S, PhD, Guazzi MD. Normalization for peak oxygen uptake increases the prognostic power of the ventilatory response to exercise in patients with chronic heart failure. Am Heart J 2003;146:542-548.
77. Forman DE, Guazzi M, Myers J, Chase P, Bensimhon D, Cahalin LP, Peberdy MA, Ashley E, West E, Daniels KM, Arena R. Ventilatory Power. A novel index that enhances prognostic assessment of patients with heart failure. Circ Heart Fail 2012;5:621-626.
78. Piepoli MF, Ponikowski PP, Volterrani M, Francis D, Coats AJ. Aetiology and pathophysiological implications of oscillatory ventilation at rest and during exercise in CHF. Do Cheyne and Stokes have an important message for modern-day patients with heart failure? Eur Heart J 1999;20:946-953.
79. Corrà U, Giordano A, Bosimini E, Mezzani A, Piepoli M, Coats AJS, Giannuzzi P. Oscillatory ventilation during exercise in patients with chronic heart failure. Clinical correlates and prognostic implications. Chest 2002;121:1572-80.
80. Kremser CB, O'Toole MF, Leff AR. Oscillatory hyperventilation in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 1987;59:900-905.
81. Leite JJ, Mansur AJ, de Freitas HF, Chizola PR, Bocchi EA, Terra-Filho M, Neder JA, Lorenzi-Filho G. Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol 2003;41:2175-2181.
82. Sun XG, Hansen JE, Beshai JF, Wasserman K. Oscillatory breathing and exercise gas exchange abnormalities prognosticate early mortality and morbidity in heart failure. J Am Coll Cardiol 2010;55:1814-1823.
83. Ingle L, Isted A, Witte KK, John GF, Cleland JGF, Clark AL. Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional oscillatory ventilation in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2009;16:451-456.
84. Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: An unfavorable combination with high prognostic value. Am Heart J 2007;153:859-867.
85. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K., ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442.
86. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996;93:1520-1526.
87. Wilkoff BL, Miller RE. Exercise testing for chronotropic assessment. Cardiol Clin 1992;10:705-717.
88. Robbins M, Francis G, Pashkow FJ, Snader CE, Hoercher K, Young JB, Lauer MS. Ventilatory and heart rate responses to exercise better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999;100:2411-2417.
89. Cohen-Solal A, Aupetit JF, Gueret P, Kolsky H, Zannad F. Can anaerobic threshold be used as an end-point for therapeutic trials in heart failure? Lessons from a multicentre randomized placebo-controlled trial. The VO2 French Study Group. Eur Heart J 1994;15:236-241.
90. Agostoni PG, Corrà U, Cattadori G, Veglia F, Battaia E, LaGioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Cicoira M, Salvioni E, Giovannardi M, Mezzani A; Scrutinio D, DiLenarda A, Mantegazza V, Ricci R, Apostolo A, Iorio AM, Paolillo S, Palermo P, Contini M, Vassanelli C, Passino C, Piepoli MF, on behalf of the MECKI Score Research Group Prognostic value of indeterminable anaerobic threshold in heart failure. Circ Heart Fail 2013;6:977-987.
91. Streitner F, Kuschyk J, Veltmann C, Brueckmann M, Streitner I, Brade J, Neumaier M, Bertsch T, Schumacher B, Borggrefe M, Wolpert C. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients: A pilot study. Cytokine 2007;40:30-34.
92. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003;348:7817-90.
93. O'Neill JO, Young JB, Pothier CE, Lauer MS. Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure. J Am Coll Cardiol 2004;44:820-826.
94. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Prediction of long-term prognosis in 12169 men referred for cardiac rehabilitation. Circulation 2002;106:666-671.
95. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 2003;42:2139-2143.
96. Agostoni PG. Cardiopulmonary exercise testing for heart failure patients: A hodgepodge of techniques, parameters and interpretations. In other words, the need for a time-break. Eur Heart J 2006;27:633-634.
97. Corrà U, Giordano A, Mezzani A, Gnemmi M, Pistono M, Giannuzzi P. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: A validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments. Eur J Prev Cardiol 2012;19:32-40.
98. Guazzi M, Arena R. The impact of pharmacotherapy on cardiopulmonary exercise test response in heart failure patients; a mini-review. Cardiovasc Pharmacol 2009;7:557-569.
99. Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997;95:1930-1936.
100. McConnell TR, Menapace FJ Jr, Hartley LH, Pfeffer MA. Captopril reduces the VE/VCO2 ratio inmyocardial infarction patients with low ejection fraction. Chest 1998;114:1289-1294.
101. Guazzi M, Palermo P, Pontone G, Susini F, Agostoni P. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure. Am J Cardiol 1999;84:1038-1043.
102. Brunner-La Rocca HP, Weilenmann D, KiowskiW, Maly FE, Candinas R, Follath F. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure. Am Heart J 1999;138:654-662.
103. Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Marino P, Zardini P. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 2002;40:304-310.
104. Agostoni P, Guazzi M, Bussotti M, De Vita S, Palermo P. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients. Chest 2002;122:2062-2067.
105. Agostoni P, Contini M, Cattadori G, Apostolo A, Sciomer S, Bussotti M, Palermo P, Fiorentini C. Lung function with carvedilol and bisoprolol in chronic heart failure: Is beta selectivity relevant? Eur J Heart Fail 2007;9:827-833.
106. Agostoni PG, Palermo P, Contini M. Respiratory effects of B-blocker therapy in heart failure. Cardiovasc Drugs Ther 2009;23:377-384.
107. Zugck C, Haunstetter A, Kruger C, Kell R, Schellberg D, Kubler W, Haass M. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 2002;39: 1615-1622.
108. Peterson LR, Schechtman KB, Ewald GA, Geltman EM, Meyer T, Krekeler P, Rogers JG. The effect of b-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J Heart Lung Transplant 2003;22:70-77.
109. Peterson LR, Schechtman KB, Ewald GA, MD, Geltman EM, MD, delasFuentes L, Meyer T, Krekeler P, Moore ML, Rogers JG. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J Heart Lung Transplant 2003;22:1141-1148.
110. Pohwani AL, Murali S, Matheir MM, Tokarczyk T, Kormos RL, McNamara DM, MacGowan AG. Impact of B-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant 2003;22:78-86.
111. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 2005;111:2313-2318.
112. Lund LH, Aaronson KD, Mancini DM. Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol 2003;92:1350-1354.
113. Tabet JY, Metra M, Thabut G, Logeart D, Cohen-Solal A. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy. Am J Cardiol 2006;98:500-503.
114. Arena RA, Guazzi M, Myers J, Abella J. The prognostic value of ventilatory efficacy with beta-blocker therapy in heart failure. Med Sci Sports Exerc 2007;39:213-219.
115. Cattadori G, Agostoni P, Corrà U, Di Lenarda A, Sinagra G, Veglia F, Salvioni E, La Gioia R, Scardovi AB, Emdin M, Metra M, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Mezzani A, Scrutinio D, Pacileo G, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Giannuzzi P, Battaia E, Cicoira M, Passino C, Piepoli MF, on behalf of the MECKI score research group. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: Role of peak oxygen consumption. Int J Cardiol 2013;168:5078-5081.
116. Myers J, Arena R, Dewey F, Bensimhon D, Abella J, Leon Hsu L, Paul Chase P, Guazzi M, Peberdy MA. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 2008;156: 1177-1183.
117. Myers J, Oliveira R, Dewey F, Arena R, Guazzi M, Chase P, Bensimhom D, Peberdy A, Ashely E, West E, Cahalin LP, Foreman DE. Validation of a cardiopulmonary exercise test score in heart failure. Circ Heart Fail 2013;6:211-218.
118. Corra U, Mezzani A, Bosimini E, Giannuzzi P. Cardiopulmonary exercise testing and prognosis in chronic heart failure: A prognosticating algorithm for the individual patient. Chest 2004;126:942-950.
119. Corrà U, Mezzani A, Giordano A, Caruso R, Giannuzzi P. A new cardiopulmonary exercise testing prognosticating algorithm for heart failure patients treated with beta-blockers. Eur J Prev Cardiol 2012;19:185-191.
120. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB, on behalf of the CHARM investigators. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75.
121. Aaronson KD, Schwatz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred to cardiac transplant evaluation. Circulation 1997;95:2660-2667.
122. Stempfle H-U, MD, A, Stief J, MD, Siebert U. The Munich Score: A clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. J Heart Lung Transplant 2008;27:222-228.
123. O'Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare, Ellis, Fine LJ Fleg JL, Zannad F, Keteyian SJ, Kitzman DW, Kraus WE, Rendall D, Pina IL, Cooper LS, Fiuzat M, Lee KL,. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: The HF-ACTION predictive risk score model. Circ Heart Fail 2011;5:63-71.
124. Agostoni PG, Corrà U, Cattadori G, Veglia F, La Gioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì, Fiorentini C, Mezzani A, Salvioni E, Scrutinio D, Ricci R, Bettari L, Di Lenarda A, Pastormerlo LE, Pacileo G, Vaninetti R, Apostolo A, Iorio AM, Paolillo S, Palermo P, Contini M, Confalonieri M, Giannuzzi P, Passantino A, DeiCas L, Piepoli MF, Passino C, on behalf of the MECKI score research group. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. Int J Cardiol 2013;167:2710-2718.
125. Chyu J, Fonarow GC, Tseng CH, Horwich TB. Four-variable risk model in men and women with heart failure. Circ Heart Fail 2014;7:88-95.